Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
19.38
+0.15 (0.78%)
At close: Feb 27, 2026

SHE:301408 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
780.71999.691,336482.1284.51206.02
Short-Term Investments
-----20
Trading Asset Securities
81.21012.41-0.55
Cash & Short-Term Investments
861.911,0101,349482.1285.01231.02
Cash Growth
-27.89%-25.14%179.76%69.16%23.37%28.45%
Accounts Receivable
543.75472.6513.14470.77294.32220.83
Other Receivables
64.7844.1236.2434.5230.8227.07
Receivables
608.53516.73549.38505.29325.14247.9
Inventory
1,030863.84772.09545.01436.19302.96
Prepaid Expenses
-15.638.272.524.2263.48
Other Current Assets
207.92191.49147.78165.2262.7479.31
Total Current Assets
2,7082,5972,8261,7001,113924.68
Property, Plant & Equipment
1,001967.8870.15533.42542.5349.62
Long-Term Investments
45.5282.292.8125.458.921.9
Goodwill
1,355988.37609.31190.06190.06153.11
Other Intangible Assets
64.6567.2162.51338.267.34
Long-Term Deferred Tax Assets
49.0640.6532.8321.9215.175.66
Long-Term Deferred Charges
84.6559.0352.1158.9792.32126.04
Other Long-Term Assets
61.1425.4865.7413.230.517.88
Total Assets
5,3694,8284,6122,5761,9711,286
Accounts Payable
1,5411,1581,027698.74468.23370.94
Accrued Expenses
60.22140.2599.84101.6879.9861.32
Short-Term Debt
309.4316.92513.51340.31150.77111.12
Current Portion of Long-Term Debt
406.63116.0210.25---
Current Portion of Leases
-210.44193.64154.24144-
Current Income Taxes Payable
33.2820.6312.334.6313.154.87
Current Unearned Revenue
38.5837.1127.0619.4111.259.94
Other Current Liabilities
105.54178.9480.3112.715.2512.59
Total Current Liabilities
2,4952,1791,9641,362882.64570.79
Long-Term Debt
475.75358.83331.1518.95--
Long-Term Leases
217.04222.85237.65248.51303.03-
Long-Term Unearned Revenue
1.710.810.91---
Long-Term Deferred Tax Liabilities
6.376.656.32---
Other Long-Term Liabilities
13.33-95.4-0.330.38
Total Liabilities
3,2092,7682,6351,6291,186571.17
Common Stock
400.01400.01400.01340340340
Additional Paid-In Capital
950.3977.861,014194.7192.99192.75
Retained Earnings
745.71627.42529.39412.58251.81182.08
Total Common Equity
2,0962,0051,944947.28784.8714.83
Minority Interest
64.0655.1433-0.270.250.24
Shareholders' Equity
2,1602,0601,977947.01785.05715.07
Total Liabilities & Equity
5,3694,8284,6122,5761,9711,286
Total Debt
1,4091,2251,286762.02597.8111.12
Net Cash (Debt)
-546.9-215.3662.53-279.92-312.8119.9
Net Cash Growth
-----495.88%
Net Cash Per Share
-1.35-0.530.16-0.82-0.940.35
Filing Date Shares Outstanding
400.01400.01400.01340340340
Total Common Shares Outstanding
400.01400.01400.01340340340
Working Capital
213.47418.84862.52338.42230.65353.89
Book Value Per Share
5.245.014.862.792.312.10
Tangible Book Value
676.85949.711,272724.22586.49554.38
Tangible Book Value Per Share
1.692.373.182.131.721.63
Buildings
-219.2238.7323.1523.1523.15
Machinery
-297.24270.1679.3865.7452.52
Construction In Progress
-168.6661.3432.240.250.87
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.